MedicaidPrior AuthMedium impact
Preferred Drug List (PDL) Update January 28, 2019 - Pharmacy Services MAB 01-19-04
Pennsylvania Medicaid (DHS)·PA·Pharmacy
Effective date
Jan 28, 2019
We identified it
Jun 20, 2026
Summary
Pennsylvania Medicaid updated their Preferred Drug List (PDL) effective January 28, 2019, changing preferred/non-preferred status for numerous medications across multiple therapeutic classes. Five preferred drugs now require clinical prior authorization: Aubagio, Linzess, Movantik, Omnitrope, and Triptodur.
Action Required
By January 28, 2019: Update prior authorization workflows for five preferred drugs that now require clinical prior authorization: Aubagio (multiple sclerosis), Linzess (GI motility), Movantik (GI motility), Omnitrope (growth hormone), and Triptodur (pituitary suppressive). Review complete PDL at https://papdl.com/preferred-drug-list to identify newly preferred vs non-preferred medications that may require prior authorization for Pennsylvania Medicaid patients.